Page 6 - Action Date News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Updated Business Strategy Focused on Small Molecule Therapeutics Kedrion to acquire, for a total of USD 17M, 2 plasma collection centers and an option to...

FDA Accepts Alkermes' Resubmission of New Drug Application for ALKS 3831 - FDA Sets PDUFA Target Action Date of June 1, 2021 - DUBLIN, Dec. 29, 2020 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of the company's New Drug Application (NDA) resubmission for ALKS 3831 (olanzapine/samidorphan) for the treatment of adults with schizophrenia and adults with bipolar I disorder, and has assigned the application a new Prescription Drug User Fee Act (PDUFA) target action date of June 1, 2021. The FDA classified the...

If it’s a single claim by one customer, go to Step 6. If it’s a joint claim by two customers, go to Step 8. Step 6 Use Function MANAGE VERIFICATION FAILURES to check which residency rules the customer has failed verification on. To do this select the record you want to investigate select [Investigate]. You will be taken to the Investigate Verification Failure screen check which residency rules the customer has failed verification on Note: Check Household Notes to check if the claim has already been referred to the Persons From Abroad (PFA) Team or International Team. If the claim has been...